Yung-Dae Yun

Title: Yung-Dae Yun: Innovator in Biotechnology

Introduction

Yung-Dae Yun is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of processes and products related to viral proteins and serine proteases. With a total of three patents to his name, Yun's work has the potential to impact medical diagnostics and therapeutics.

Latest Patents

Yun's latest patents include a novel process for preparing hepatitis C virus envelope glycoproteins. This invention utilizes Chinese Hamster Ovary (CHO) cells transformed with recombinant expression vectors containing the hepatitis C virus genome. The process allows for the massive production of HCV E1 and E2/NS1 envelope glycoproteins, which can be applied in the development of diagnostic reagents and potential preventive vaccines for hepatitis C.

Another significant patent is the cDNA of a direct-acting fibrinolytic serine protease, known as 'Salmonase', derived from the Korean viper, Agkistrodon halys brevicaudus. This cDNA consists of 699 nucleotides coding for 233 amino acids. The recombinant Salmonase produced from this cDNA can be utilized as an active ingredient in thrombolytic and hemostatic agents.

Career Highlights

Yung-Dae Yun is affiliated with the Mogam Biotechnology Research Institute, where he conducts his research and development activities. His work has garnered attention for its innovative approaches to solving complex biological problems.

Collaborations

Yun collaborates with notable colleagues, including Hong-Mo Moon and Mi-Kyung Min, who contribute to his research endeavors and help advance the field of biotechnology.

Conclusion

Yung-Dae Yun's contributions to biotechnology through his patents and research at the Mogam Biotechnology Research Institute highlight his role as an influential inventor. His work has the potential to lead to significant advancements in medical science and therapeutic applications.